Abstract
Recently, the interest of the cardiology community has been focused on the results of the latest studies on the use of vasodilating β-blockers in patients with arterial hypertension. A review of these studies demonstrates a number of advantages over conventional cardioselective drugs (without vasodilator properties). The positive features of vasodilating β-adrenoblockers are proven metabolic neutrality, proportional reduction of central and peripheral blood pressure, minimal effect on bronchial patency, the absence of negative effect on erectile function, reduction in the frequency of cardiovascular complications in patients with arterial hypertension.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
